Nilotinib restores long-term full-donor chimerism in Ph-positive acute lymphoblastic leukemia relapsed after allogeneic transplantation

Bone Marrow Transplant. 2009 Aug;44(4):263-4. doi: 10.1038/bmt.2009.6. Epub 2009 Feb 9.

Authors

S Merante, A A Colombo, S Calatroni, B Rocca, M Boni, P Bernasconi, L Bonvini, S Soverini, E P Alessandrino

PMID: 19204710
DOI: 10.1038/bmt.2009.6

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Agents / therapeutic use*
Benzamides
Humans
Imatinib Mesylate
Piperazines / therapeutic use*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Pyrimidines / therapeutic use*
Tissue Donors
Transplantation Chimera

Substances

Antineoplastic Agents
Benzamides
Piperazines
Pyrimidines
Imatinib Mesylate